Skip to main content

Table 1 Baseline characteristics and outcome of 16 critically ill COVID-19 patients

From: What every intensivist should know about Tocilizumab

Age (years)

55.5 [47–63] (48–63)

BMI (kg/m2)

30.5 [26–33] (27–32)

Male gender

7/16 (43.8%)

Comorbidities

 

Arterial hypertension

5/16 (31.3%)

CAD

1/16 (6.3%)

COPD

1/16 (6.3%)

Diabetes mellitus

4/16 (25%)

Chronic kidney disease

3/16 (18.8%)

SOFA score at ICU admission

11 [06–12] (11–12)

Invasive mechanical ventilation

13/16 (81.3%)

ICU survival

9/16 (56.3%)

Length of ICU stay (d)

26 [18–31] (19–32)

Steroids before Tocilizumab administration

13/16 (81.3%)

  1. Results provided as absolute numbers and (percentages) or as median, [interquartile range] and (95% confidence interval), as appropriate
  2. BMI body mass index, CAD coronary artery disease, COPD chronic obstructive pulmonary disease, SOFA score sequential organ failure assessment score, ICU; intensive care unit